News & Events

StageBio Announces David Bruning as New CEO & President

StageBio is delighted to announce that David Bruning is joining our team as our new CEO and President. Bringing over 25 years of leadership experience in a multitude of roles, including five years serving on the StageBio Board of Directors, Mr. Bruning's industry knowledge positions him to guide StageBio to a successful future.

Read the full press release here.

For additional questions, contact our team. StageBio is a leading provider of GLP-compliant histology, pathology, image analysis and archiving services for both preclinical and clinical research.

Back to Index

Learn more about StageBio’s COVID-19 response